Kestra Medical Technologies Income Statement (2024-2025) | KMTS

Income Statement Jan2024 Apr2024 Jul2024 Oct2024 Jan2025 Apr2025 Jul2025 Oct2025
Revenue & cost
Revenue 8.28M10.05M12.78M14.71M15.09M17.23M19.37M22.57M
Cost of Revenue 7.40M8.66M8.58M8.88M8.54M9.60M10.52M11.14M
Gross Profit 0.88M1.40M4.20M5.83M6.55M7.63M8.85M11.42M
Operating items
Research & Development 3.73M3.82M3.40M3.51M3.35M5.39M4.00M4.88M
Selling, General & Administrative 17.09M17.93M19.23M21.45M23.80M50.46M33.73M38.30M
Operating Expenses 20.83M21.75M22.63M24.96M27.15M55.84M37.73M43.18M
Operating Income -19.95M-20.35M-18.43M-19.13M-20.60M-48.21M-28.88M-31.75M
EBIT -19.95M-20.35M-18.43M-19.13M-20.60M-48.21M-28.88M-31.75M
Non-operating items
Interest & Investment Income 0.04M0.88M0.63M1.66M2.17M1.80M
Other Non Operating Income -0.01M-0.03M-0.05M-0.04M0.01M3.63M2.83M-0.89M
Non Operating Income -0.01M-0.03M-0.05M-0.04M0.01M-2.69M2.83M-0.89M
Net income details
EBT -21.61M-22.31M-20.32M-20.61M-21.74M-51.01M-25.79M-32.75M
Tax Provisions 0.01M-0.03M0.01M0.01M0.02M0.10M0.03M0.03M
Profit After Tax -21.62M-22.28M-20.32M-20.62M-21.76M-51.11M-25.83M-32.78M
Income from Non-Controlling Interests -0.44M-0.25M-0.25M
Income from Continuing Operations -21.62M-22.28M-20.32M-20.62M-21.76M-51.11M-25.83M-32.78M
Consolidated Net Income -21.62M-22.28M-20.32M-20.62M-21.76M-51.11M-25.83M-32.78M
Income towards Parent Company -21.62M-22.28M-20.32M-20.62M-21.76M-51.11M-25.83M-32.78M
Preferred Dividend Payments 1.81M1.99M2.38M3.32M3.32M3.29M
Net Income towards Common Stockholders -23.43M-24.28M-22.27M-23.69M-24.83M-55.34M-25.83M-32.78M
Additional items
EPS (Basic) -1.18-1.22-1.12-1.19-1.25-1.57-0.50-0.64
EPS (Weighted Average and Diluted) -1.18-1.22-1.12-1.19-1.25-1.57-0.50-0.64
Shares Outstanding (Weighted Average) 37.65M37.65M37.65M37.65M51.35M51.35M51.45M
Shares Outstanding (Diluted Average) 19.89M19.89M19.89M19.89M19.89M24.58M51.30M51.38M
EBITDA -19.95M-20.35M-18.43M-19.13M-20.60M-48.21M-28.88M-31.75M
Interest Expenses 1.65M1.94M1.87M2.32M1.78M1.76M1.91M1.90M
Tax Rate 0.12%